REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206,689 | -54.7% | 18,020 | 0.0% | 0.01% | -38.9% |
| Q2 2023 | $456,086 | -21.4% | 18,020 | 0.0% | 0.02% | -30.8% |
| Q1 2023 | $580,424 | +74.5% | 18,020 | 0.0% | 0.03% | +73.3% |
| Q4 2022 | $332,649 | -59.3% | 18,020 | -40.4% | 0.02% | -59.5% |
| Q3 2022 | $817,000 | +95.5% | 30,256 | 0.0% | 0.04% | +131.2% |
| Q2 2022 | $418,000 | -27.7% | 30,256 | +2.0% | 0.02% | -30.4% |
| Q1 2022 | $578,000 | +19.4% | 29,657 | 0.0% | 0.02% | +15.0% |
| Q4 2021 | $484,000 | -40.7% | 29,657 | +1.3% | 0.02% | -51.2% |
| Q3 2021 | $816,000 | -6.0% | 29,274 | 0.0% | 0.04% | -6.8% |
| Q2 2021 | $868,000 | +6.1% | 29,274 | 0.0% | 0.04% | 0.0% |
| Q1 2021 | $818,000 | -99.9% | 29,274 | 0.0% | 0.04% | -8.3% |
| Q4 2020 | $829,625,000 | – | 29,274 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
| Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
| Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
| Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
| FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
| Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
| Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |